BL
BLFS icon

Bleichroeder LP’s BioLife Solutions BLFS Stock Holding History

Bleichroeder LP’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-211,942
Closed -$3.46M – 77
2020
Q2 		$3.46M Hold
211,942
– – 0.61% 29
2020
Q1 		$2.01M Buy
+211,942
New +$2.91M 0.53% 34

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Bleichroeder LP's BLFS Position: Q3 2020 in Review

Bleichroeder LP sold out of BioLife Solutions (BLFS) in Q3 2020, closing a stake of 211,942 shares — an estimated $3.46M sold.

Bleichroeder LP first reported a position in BLFS in Q1 2020 and held it in 2 quarters. The position peaked at $3.46M in Q2 2020. 108 funds tracked by Wall St. Rank hold BLFS as of Q3 2020.

  • Bleichroeder LP reported no remaining BioLife Solutions position as of Q3 2020 after selling out during the quarter.
  • Bleichroeder LP sold 211,942 BioLife Solutions shares in Q3 2020, an estimated $3.46M.
  • Bleichroeder LP first reported a position in BioLife Solutions in Q1 2020 and held it in 2 quarters.
  • Bleichroeder LP's BioLife Solutions position peaked at $3.46M in Q2 2020.
  • 108 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2020.

Based on Bleichroeder LP's 13F filing for Q3 2020, filed 12 Nov 2020.